AdisInsight

@NewAdisInsight

We publish a database of drugs, trials. deals and safety, based on trusted, scientifically sound data. Site notice

Global
Vrijeme pridruživanja: listopad 2014.

Tweetovi

Blokirali ste korisnika/cu @NewAdisInsight

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NewAdisInsight

  1. 22. stu 2019.

    Are you attending Asia this December? Visit us at our stand to see how can help you and receive a FREE competitive intelligence report. To find out more and to pre-register your interest, click here:

    Poništi
  2. proslijedio/la je Tweet
    8. lis 2019.

    Are you attending Italian Day next week? Visit us at our stand to see how can help you and receive a FREE safety report. To find out more and to pre-register your interest, click here

    Poništi
  3. proslijedio/la je Tweet
    19. ruj 2019.

    ⁩ is attending the ⁦⁩ in Newark NJ!

    Poništi
  4. 19. ruj 2019.

    It's day two , don’t forget to visit our booth and get your FREE competitive intelligence report.

    Poništi
  5. proslijedio/la je Tweet
    18. ruj 2019.

    is attending the PharmaCI Conference in Newark NJ. Stop by the booth at the to see how AdisInsight can help you and enter a chance to win an Amazon Echo!

    Poništi
  6. 18. ruj 2019.

    Stop by our booth today USA to see how can help you and receive a FREE competitive intelligence report.

    Poništi
  7. 5. ruj 2019.

    Are you attending USA this September? Visit us at our stand to see how AdisInsight can help you and receive a FREE competitive intelligence report. To find out more and to pre-register your interest, click here:

    Poništi
  8. 15. stu 2018.

    Browse mellitus from . Free content in the form of a virtual issue PLUS two webinars on “Precision Diabetes” and “Future of Insulin”

    Poništi
  9. proslijedio/la je Tweet

    Over 180 articles, book chapters and books by this year’s winners have been published by . Read more in our latest

    Poništi
  10. 11. lis 2018.

    Browse ’s research from . Free content in the form of a virtual issue, explore the latest research on diagnosis, treatment and prevention by leveraging a variety of techniques and technologies.

    Poništi
  11. 28. kol 2018.

    Browse research from incl. webinar about "Innovations & Trends in " and white paper on “, and

    Poništi
  12. proslijedio/la je Tweet
    22. kol 2018.

    Have you viewed the 5 Global Grand Challenges Infographic yet? Here's a snippet, but view the entire image here:

    Poništi
  13. 7. kol 2018.

    Avatrombopag (®): First Global Approval – Reducing the bleeding risks of invasive procedures in patients with Chronic Liver Disease

    Poništi
  14. proslijedio/la je Tweet

    Interested in seeing how having access to STM content accelerates innovation ? Read the latest white paper! From Research to Patent and Back Again: The research needs of R&D professionals

    Poništi
  15. 1. kol 2018.

    Erenumab (™) developed by and : First Global Approval in US followed by Positive CHMP Opinion – Once-monthly prophylactic approach for adults with

    Poništi
  16. proslijedio/la je Tweet

    What does it take to write a book that doesn't fit into the traditional academic framework? Tips and advice from a Springer Nature author on the Source blog.

    Poništi
  17. 18. srp 2018.
    Poništi
  18. 17. srp 2018.
    Poništi
  19. 17. srp 2018.
    Poništi
  20. 13. srp 2018.

    Call for Papers: Themed Issue – Improving Transparency in Decision Models

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·